BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2003
View Archived Issues
Integrated pharmacokinetic/pharmacodynamic model developed for SB-480848
Read More
Garenoxacin pharmacokinetics similar in healthy and hepatically impaired subjects
Read More
Pharmacokinetics, metabolism and excretion of single-dose sitafloxacin in healthy males
Read More
Food intake does not alter the pharmacokinetics of multiple-dose lonafarnib
Read More
No pharmacokinetic interactions for memantine and donepezil in healthy volunteers
Read More
DOV reacquires diltiazem rights from Biovail
Read More
Results of argatroban and gpIIb/IIIa inhibitor combination study
Read More
Isis outlines 2003/4 milestones
Read More
New patent broadens protection for Virulizin
Read More
Sumitomo presents new muscarinic M3 antagonists for use in urinary incontinence
Read More
Novel PARP inhibitors in early development at Icos
Read More
JT researchers prepare and test new HIV integrase inhibitors
Read More
New antitumor duocarmycin analogues covered by Medarex patent
Read More
Novel sodium channel blockers for pain, seizures and other disorders
Read More
E.U. approval for NeoRecormon use once every two weeks for renal anemia
Read More
Metvix PDT approved in Australia
Read More
Remicade approved for long-term use in fistulizing Crohn's disease
Read More
Biosyn acquires rights to HIV microbicide candidate from NIH
Read More
AP-5346 enters phase I trials in Europe
Read More
Brand name announced for decitabine
Read More
Graffinity enters research collaboration with Serono
Read More
Ongoing program for clopidogrel in atherosclerosis
Read More
HYB-2055 enters the clinic
Read More
Water-soluble taxoids for use in tumor-activated prodrugs
Read More